Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07174765
Active, not recruiting Observational

Population-Based Analysis of Incidence and Mortality of Septic Shock

NCT07174765 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2018-01-01
Last updated
2025-09-16

Condition(s) studied

Septic Shock

Investigational drug(s) / intervention(s)

Person-level linkage of the database looking for relationship with septic shock survival and comorbidities, previous intake of medication, and previous dependence on health services.

Person-level linkage of the database looking for relationship with septic shock survival and comorbidities, previous intake of medication, and previous dependence on health services.: A descriptive analysis of the baseline demographics, risk factors, health status, comorbidities, frailty, and previous dependence on health services of all patients admitted with septic shock to hospitals in the region will be carried out. The overall data of patients admitted to hospitals will be analysed. The survival data of patients will be compared with their previous individual drug consumption and inhospital survival to septic shock. In addition, drug dependence and dependence on health services of survivors will be studied in comparison with their situation prior to sepsis. The objective is to establish the Registry of Administrative Data Automatically Recorded for Septic Shock (RADAR-Septic Shock), leveraging administrative data to characterize septic shock incidence, describe patient profiles, identify population-specific healthcare needs, and provide benchmark values for performance assessment in Catalonia's public health system.

Study summary

RADAR-Septic Shock is a population-based observational study in Catalonia (Spain) that will identify all hospital discharges with septic shock between 2018 and 2023 using an audited population-based registry. The project will quantify incidence, describe patient characteristics and resource use, and compare risk-adjusted in-hospital mortality across hospitals to support quality improvement. Cases are defined by ICD-10 codes for septic shock (R65.21) and post-procedural septic shock (T81.12XA). In preliminary cohort counts, \>31,000 episodes were identified across 2018-2023; in 2023 the incidence was \~78 per 100,000 inhabitants with an overall in-hospital mortality of \~33%, higher in hospital-acquired than community-acquired episodes

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with a diagnosis of septic shock admitted to the hospitals of the public hospital network of Catalonia, Spain. Septic shock will be defined using the methodology described by Angus et al., which is currently referenced for population-based studies, consisting of coding a diagnosis of infection with acute organ failure, or sepsis or septic shock. Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital General de Granollers Granollers Barcelona

More Hospital de Granollers trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07174765 on ClinicalTrials.gov ↗ ← All trials in Spain